Hypertension Treatment, Blood Pressure, and Deprescribing Among US Nursing Home Residents With and Without Dementia Before and After the COVID-19 Pandemic.

ABSTRACT:

Objectives

To evaluate hypertension (HTN) management and antihypertensive deprescribing among US nursing home (NH) residents with and without dementia, before and after the onset of the COVID-19 pandemic.

Design

Retrospective cohort study.

Setting and participants

Newly admitted NH residents with HTN treated with an antihypertensive medication who were not receiving hospice from >1100 NHs using a common electronic health record vendor (January 2, 2018-July 3, 2022) (N = 141,630).

Methods

During an 8-week follow-up period beginning on day 14 in the NH after admission (index date), we measured average blood pressure (BP), BP variability, and prevalence of hypo-/hypertension stratified by dementia status and pre- and post-COVID-19 onset (admission before vs on/aft

SUBMITTER: Zhang S 

PROVIDER: S-EPMC12581180 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature